ATE298742T1 - Zykloalkenylsulfonamidderivate - Google Patents
ZykloalkenylsulfonamidderivateInfo
- Publication number
- ATE298742T1 ATE298742T1 AT02733989T AT02733989T ATE298742T1 AT E298742 T1 ATE298742 T1 AT E298742T1 AT 02733989 T AT02733989 T AT 02733989T AT 02733989 T AT02733989 T AT 02733989T AT E298742 T1 ATE298742 T1 AT E298742T1
- Authority
- AT
- Austria
- Prior art keywords
- cycloalkenylsulfonamide
- derivatives
- useful
- psychiatric
- patient
- Prior art date
Links
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29442801P | 2001-05-30 | 2001-05-30 | |
| PCT/US2002/011895 WO2002098847A1 (en) | 2001-05-30 | 2002-05-17 | Cycloalkenylsulfonamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298742T1 true ATE298742T1 (de) | 2005-07-15 |
Family
ID=23133381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02733989T ATE298742T1 (de) | 2001-05-30 | 2002-05-17 | Zykloalkenylsulfonamidderivate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040157817A1 (de) |
| EP (1) | EP1395550B1 (de) |
| JP (1) | JP2004529978A (de) |
| AT (1) | ATE298742T1 (de) |
| CA (1) | CA2447746A1 (de) |
| DE (1) | DE60204882D1 (de) |
| WO (1) | WO2002098847A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| MX2007001678A (es) * | 2004-08-09 | 2007-04-12 | Glaxo Group Ltd | Compuestos que potencian el receptor de glutamato y sus usos en medicina. |
| TWI446908B (zh) * | 2005-06-06 | 2014-08-01 | Lilly Co Eli | Ampa受體強化劑 |
| DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| JP5014334B2 (ja) * | 2005-10-06 | 2012-08-29 | イーライ リリー アンド カンパニー | Ampa受容体増強剤 |
| GB0602560D0 (en) * | 2006-02-08 | 2006-03-22 | Glaxo Group Ltd | Compounds |
| EP2356099A1 (de) * | 2008-10-08 | 2011-08-17 | Pfizer Inc. | Tetrahydorfuranylsulfonamide zur verwendung als ampa-modulatoren bei der behandlung von zns-erkrankungen |
| WO2014201411A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
| WO2018009256A1 (en) | 2016-03-29 | 2018-01-11 | Respirerx Pharmaceuticals, Inc. | Compositions and methods for treating attention deficit disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| DE69917278T2 (de) * | 1998-07-31 | 2005-05-19 | Eli Lilly And Co., Indianapolis | Heterocyclyl sulphonamid derivate |
| US6358981B1 (en) * | 1998-07-31 | 2002-03-19 | Eli Lilly And Company | Sulphonamide derivatives |
| US6500865B1 (en) * | 1998-07-31 | 2002-12-31 | Eli Lilly And Company | Sulfonamide derivatives |
| CA2338862A1 (en) * | 1998-07-31 | 2000-02-10 | Dennis Michael Zimmerman | Alkenyl sulphonamide derivatives |
| US6639107B1 (en) * | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
-
2002
- 2002-05-17 US US10/477,029 patent/US20040157817A1/en not_active Abandoned
- 2002-05-17 DE DE60204882T patent/DE60204882D1/de not_active Expired - Lifetime
- 2002-05-17 JP JP2003501837A patent/JP2004529978A/ja not_active Withdrawn
- 2002-05-17 WO PCT/US2002/011895 patent/WO2002098847A1/en not_active Ceased
- 2002-05-17 CA CA002447746A patent/CA2447746A1/en not_active Abandoned
- 2002-05-17 AT AT02733989T patent/ATE298742T1/de not_active IP Right Cessation
- 2002-05-17 EP EP02733989A patent/EP1395550B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002098847A1 (en) | 2002-12-12 |
| EP1395550B1 (de) | 2005-06-29 |
| EP1395550A1 (de) | 2004-03-10 |
| CA2447746A1 (en) | 2002-12-12 |
| JP2004529978A (ja) | 2004-09-30 |
| DE60204882D1 (de) | 2005-08-04 |
| US20040157817A1 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6922A (is) | Heterófjölhringjaefnasambönd og notkun þeirra semmetabótrópísk mótlyf gegn glútamat viðtökum | |
| UA87856C2 (ru) | Алкильные производные как модуляторы метаботропных рецепторов глутамата | |
| DE69820632D1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate | |
| MXPA04006271A (es) | Derivados de indolinona utiles como inhibidores de la proteina cinasa. | |
| DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| MY127686A (en) | Monofluoroalkyl derivatives | |
| ATE272617T1 (de) | Sulfonamid-derivate | |
| WO2000006083A3 (en) | Sulfonamide derivatives | |
| EA200301143A1 (ru) | Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| WO2002014294A3 (en) | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function | |
| WO2002014275A3 (en) | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function | |
| ATE298742T1 (de) | Zykloalkenylsulfonamidderivate | |
| DE50201565D1 (de) | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| DK1399438T3 (da) | Hidtil ukendte heteroarylderivater samt fremstilling og anvendelse heraf | |
| DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
| YU22802A (sh) | Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina | |
| MY136138A (en) | Hexacyclic compounds | |
| SI1603877T1 (sl) | Novi derivati aminopiridina kot antagonisti mGiuR5 | |
| DK1368336T3 (da) | Thiophensubstituerede aminderivater som GlyT-1-inhibitorer | |
| MXPA03011766A (es) | Novedosos derivados de indol. | |
| DE60203740D1 (de) | Luminacine analoge und deren verwendung | |
| EA200501053A1 (ru) | Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |